Brookdale Senior Living Inc
XBER:B7S
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Brookdale Senior Living Inc
XBER:B7S
|
US |
|
Inovio Pharmaceuticals Inc
LSE:0A43
|
US |
|
Heineken Holding NV
AEX:HEIO
|
NL |
|
E
|
Empire State Realty Trust Inc
F:ES9
|
US |
|
C
|
Carlos Casado SA
BCBA:CADO5
|
AR |
|
Rekor Systems Inc
NASDAQ:REKR
|
US |
|
Brickability Group PLC
F:71T
|
UK |
|
F
|
Fuchs Se
SWB:FPE4
|
DE |
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
JP |
|
Fubon Financial Holding Co Ltd
TWSE:2881
|
TW |
|
SeaWorld Entertainment Inc
NYSE:PRKS
|
US |
Wall St Price Targets
B7S Price Targets Summary
Brookdale Senior Living Inc
According to Wall Street analysts, the average 1-year price target for B7S is 12.45 EUR with a low forecast of 10.7 EUR and a high forecast of 15.05 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is B7S's stock price target?
Price Target
12.45
EUR
According to Wall Street analysts, the average 1-year price target for B7S is 12.45 EUR with a low forecast of 10.7 EUR and a high forecast of 15.05 EUR.
What is the Revenue forecast for Brookdale Senior Living Inc?
Projected CAGR
1%
Over the last 13 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 3 years is 1%.
What is the Operating Income forecast for Brookdale Senior Living Inc?
Projected CAGR
57%
Over the last 13 years, the compound annual growth rate for Operating Income has been -3%. The projected CAGR for the next 3 years is 57%.
